Literature DB >> 22006270

The role of APP and APLP for synaptic transmission, plasticity, and network function: lessons from genetic mouse models.

Martin Korte1, Ulrike Herrmann, Xiaomin Zhang, Andreas Draguhn.   

Abstract

APP, APLP1, and APLP2 form a family of mammalian membrane proteins with unknown function. APP, however, plays a key role in the molecular pathology of Alzheimer's disease (AD), indicating that it is somehow involved in synaptic transmission, synaptic plasticity, memory formation, and maintenance of neurons. At present, most of our knowledge about the function of APP comes from consequences of AD-related mutations. The native role of APP, and even more of APLP1/2, remains largely unknown. New genetic knockout and knockin models involving several members of the APP/APLP family may yield better insight into the synaptic and systemic functions of these proteins. Here, we summarize recent results from such transgenic animals with special emphasis on synaptic plasticity and coherent patterns of memory-related network activity in the hippocampus. Data from APP knockout mice suggest that this protein is needed for the expression of long-term potentiation (LTP) in aged, but not in juvenile mice. The missing function can be rescued by expressing part of the protein, as well as by blocking inhibition. Double knockout mice lacking APP and APLP2 die shortly after birth indicating that different members of the APP/APLP family can mutually compensate for genetic ablation of single proteins. Recent techniques allow for analysis of tissue with combined defects, e.g., by expressing only part of APP in APLP2 knockout mice or by growing stem cells with multiple deletions on normal slice cultures. Data from these experiments confirm that APP and APLP2 do indeed play an important role in synaptic plasticity. Much less is known about the role of APP/APLP at the network level. Coherent patterns of activity like hippocampal network oscillations are believed to support formation and consolidation of memory. Analysis of such activity patterns in tissue from mice with altered expression of APP/APLP has just started and may shed further light on the importance of these proteins for cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006270     DOI: 10.1007/s00221-011-2894-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  43 in total

1.  Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices.

Authors:  S M Fitzjohn; R A Morton; F Kuenzi; C H Davies; G R Seabrook; G L Collingridge
Journal:  Neurosci Lett       Date:  2000-07-07       Impact factor: 3.046

2.  Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein.

Authors:  G R Dawson; G R Seabrook; H Zheng; D W Smith; S Graham; G O'Dowd; B J Bowery; S Boyce; M E Trumbauer; H Y Chen; L H Van der Ploeg; D J Sirinathsinghji
Journal:  Neuroscience       Date:  1999-04       Impact factor: 3.590

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Hippocampal electrical activity and voluntary movement in the rat.

Authors:  C H Vanderwolf
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1969-04

5.  Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice.

Authors:  J P Steinbach; U Müller; M Leist; Z W Li; P Nicotera; A Aguzzi
Journal:  Cell Death Differ       Date:  1998-10       Impact factor: 15.828

6.  Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein.

Authors:  G R Seabrook; D W Smith; B J Bowery; A Easter; T Reynolds; S M Fitzjohn; R A Morton; H Zheng; G R Dawson; D J Sirinathsinghji; C H Davies; G L Collingridge; R G Hill
Journal:  Neuropharmacology       Date:  1999-03       Impact factor: 5.250

7.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.

Authors:  Jochen Herms; Brigitte Anliker; Sabine Heber; Sabine Ring; Martin Fuhrmann; Hans Kretzschmar; Sangram Sisodia; Ulrike Müller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

Review 8.  Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.

Authors:  Thomas Klausberger; Peter Somogyi
Journal:  Science       Date:  2008-07-04       Impact factor: 47.728

9.  Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.

Authors:  D Hermann; M Both; U Ebert; G Gross; H Schoemaker; A Draguhn; K Wicke; V Nimmrich
Journal:  Neuroscience       Date:  2009-05-27       Impact factor: 3.590

Review 10.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

Authors:  Paul R Turner; Kate O'Connor; Warren P Tate; Wickliffe C Abraham
Journal:  Prog Neurobiol       Date:  2003-05       Impact factor: 11.685

View more
  29 in total

1.  The physiological functions of the β-amyloid precursor protein APP.

Authors:  Ulrike C Müller; Claus U Pietrzik; Thomas Deller
Journal:  Exp Brain Res       Date:  2012-04       Impact factor: 1.972

Review 2.  From FMRP function to potential therapies for fragile X syndrome.

Authors:  Ferzin Sethna; Changjong Moon; Hongbing Wang
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

3.  Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome.

Authors:  Lucas J Sosa; Nienke L Postma; Adriana Estrada-Bernal; M Hanna; R Guo; Jorge Busciglio; Karl H Pfenninger
Journal:  FASEB J       Date:  2013-09-13       Impact factor: 5.191

4.  Analysis of Motor Function in Amyloid Precursor-Like Protein 2 Knockout Mice: The Effects of Ageing and Sex.

Authors:  Phan H Truong; Giuseppe D Ciccotosto; Roberto Cappai
Journal:  Neurochem Res       Date:  2018-10-25       Impact factor: 3.996

5.  Systems genetics of intravenous cocaine self-administration in the BXD recombinant inbred mouse panel.

Authors:  Price E Dickson; Mellessa M Miller; Michele A Calton; Jason A Bubier; Melloni N Cook; Daniel Goldowitz; Elissa J Chesler; Guy Mittleman
Journal:  Psychopharmacology (Berl)       Date:  2015-11-19       Impact factor: 4.530

6.  The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease.

Authors:  Anna Pliássova; João P Lopes; Cristina Lemos; Catarina R Oliveira; Rodrigo A Cunha; Paula Agostinho
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

7.  The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.

Authors:  Maja Klevanski; Ulrike Herrmann; Sascha W Weyer; Romain Fol; Nathalie Cartier; David P Wolfer; John H Caldwell; Martin Korte; Ulrike C Müller
Journal:  J Neurosci       Date:  2015-12-09       Impact factor: 6.167

8.  Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells.

Authors:  Haley L Peters; Amit Tuli; Xiaojian Wang; Cuiling Liu; Zenggang Pan; Michel M Ouellette; Michael A Hollingsworth; Richard G Macdonald; Joyce C Solheim
Journal:  Int J Oncol       Date:  2012-07-13       Impact factor: 5.650

9.  Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance.

Authors:  Lucas J Sosa; Jared Bergman; Adriana Estrada-Bernal; Thomas J Glorioso; John M Kittelson; Karl H Pfenninger
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  Hippocampal network oscillations in APP/APLP2-deficient mice.

Authors:  Xiaomin Zhang; Ulrike Herrmann; Sascha W Weyer; Martin Both; Ulrike C Müller; Martin Korte; Andreas Draguhn
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.